Abstract:Floxuridine (FUdR, 5-fluoro-2-deoxyuridine) was widely used in patients with tumor. But the poor activity and severe side effects have been observed in the clinic, which resulted from increased degradation cleavage of FUdR to 5-FU by thymidine phosphorylase and reduced transporter-mediated entry into cells. In this study, we have synthesized a series of l-aspartic acid β-esters and l-glutamic acid γ-esters of FUdR to improve the metabolic stability of FUdR and target FUdR to cancer cells via amino acid transporter ATB0,+ which was exclusively up-regulated in some cancerous tissue. The uptake mechanism, stability, in vitro/in vivo antiproliferation action, pharmacokinetics, and tissue distribution were studied. The combined results showed the unusual 5′-β-l-Asp-FUdR possessed a better tumor inhibition rate and a better metabolic stability than FUdR through a ATB0,+-mediated prodrug approach. The present study provided the first proof-of-concept of exploiting ATB0,+ for tumor-selective delivery of nucleoside analogues in the form of prodrug.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c00149?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00149</a>.1H NMR (400 MHz, DMSO-d6), 13C NMR (100 MHz, DMSO-d6), and HPLC of 5′-α-l-Val-FUdR, 3′-α-l-Val-FUdR, 3′,5′-di-α-l-Val-FUdR, 5′-β-l-Asp-FUdR, 3′-β-l-Asp-FUdR, 3′,5′-di-β-l-Asp-FUdR, 5′-γ-l-Glu-FUdR, 3′-γ-l-Glu-FUdR, and 3′,5′-di-γ-l-Glu-FUdR (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00149/suppl_file/jm0c00149_si_001.pdf">PDF</a>)Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00149/suppl_file/jm0c00149_si_002.csv">CSV</a>)Coordinates of homology models for ATB0,+ (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00149/suppl_file/jm0c00149_si_003.pdb">PDB</a>)This article has not yet been cited by other publications.

[Preparation of Floxuridine Loaded Polycation and Its Antitumor Activity].

[Preparation of 5-Fluorouracil Encapsulated in Amphiphilic Polysaccharide Nano-Micelles and Its Killing Effect on Hepatocarcinoma Cell Line HepG2].

Design, Synthesis, and Evaluation of Doxifluridine Derivatives as Nitroreductase-Responsive Anticancer Prodrugs

Discovery of an Orally Active and Liver-Targeted Prodrug of 5-Fluoro-2 '-Deoxyuridine for the Treatment of Hepatocellular Carcinoma

Bifunctional and Unusual Amino Acid β- or γ-Ester Prodrugs of Nucleoside Analogues for Improved Affinity to ATB 0,+ and Enhanced Metabolic Stability: An Application to Floxuridine

An acid-activatable fluorouracil prodrug for colorectal cancer synergistic therapy

Novel ProTide Prodrugs of 5-Fluoro-2′-deoxyuridine for the Treatment of Liver Cancer

Optimized 5-Fluorouridine Prodrug for Co-Loading with Doxorubicin in Clinically Relevant Liposomes

Novel Poly-Β-cyclodextrin Derivatives As Advanced Carriers for 5-Fluorouracil for Tumor: the Impact of Charge on Antitumor Efficiency.

Floxuridine Homomeric Oligonucleotides "hitchhike" with Albumin in Situ for Cancer Chemotherapy.

Esterase-Responsive Floxuridine-Tethered Multifunctional Nanoparticles for Targeted Cancer Therapy

Development of new promising antimetabolite, DFP-11207 with self-controlled toxicity in rodents

Preparation of floxuridine diacetate solid lipid nanoparticles

Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators

Synthesis and Activity Evaluation of 3′‐floxuridinyl 4‐[3‐(3, 5‐di‐t‐butyl‐4‐methoxyphenyl)‐3‐oxo‐propenyl]benzoate: in Vitro and in Vivo As a Potential Dual‐acting Antitumor Prodrug

Preparation and Evaluation of a Novel Anticancer Drug Delivery Carrier for 5-Fluorouracil Using Synthetic Bola-Amphiphile Based on Lysine As Polar Heads.

Bifunctional Conjugates Comprising Β-Cyclodextrin, Polyethylenimine, and 5-Fluoro-2'- Deoxyuridine for Drug Delivery and Gene Transfer.

Floxuridine-loaded Silk Fibroin Nanospheres

Surface decoration of PLGA nanoparticles enables efficient transport of floxuridine oligomers into mammalian cells

5-Fluorouracil-Loaded PLGA Nanoparticles: Formulation, Physicochemical Characterisation, and In VitroAnti-Cancer Activity

Experimental study of 5-fluorouracil loaded polylactic acid nanoparticles control-releasing preparation on tumor